 Michael Mohning
Concepts (143)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Idiopathic Pulmonary Fibrosis | 6 | 2026 | 692 | 1.150 |
Why?
| | Lung Diseases, Interstitial | 4 | 2025 | 664 | 0.970 |
Why?
| | Asthma, Exercise-Induced | 1 | 2024 | 14 | 0.860 |
Why?
| | Bronchoconstriction | 1 | 2024 | 29 | 0.860 |
Why?
| | Spirometry | 1 | 2025 | 233 | 0.850 |
Why?
| | Exercise Test | 3 | 2026 | 630 | 0.800 |
Why?
| | Cough | 2 | 2015 | 124 | 0.790 |
Why?
| | Dyspnea | 2 | 2015 | 250 | 0.750 |
Why?
| | Alveolitis, Extrinsic Allergic | 4 | 2026 | 93 | 0.680 |
Why?
| | Oxygen Consumption | 2 | 2022 | 718 | 0.610 |
Why?
| | Acute Lung Injury | 3 | 2017 | 305 | 0.590 |
Why?
| | Tomography, X-Ray Computed | 5 | 2025 | 2769 | 0.570 |
Why?
| | Lung Diseases | 1 | 2025 | 780 | 0.560 |
Why?
| | c-Mer Tyrosine Kinase | 1 | 2017 | 39 | 0.520 |
Why?
| | Cell-Derived Microparticles | 1 | 2017 | 73 | 0.480 |
Why?
| | Phagocytosis | 1 | 2017 | 296 | 0.460 |
Why?
| | Receptor Protein-Tyrosine Kinases | 1 | 2017 | 231 | 0.450 |
Why?
| | Macrophages, Alveolar | 1 | 2017 | 373 | 0.420 |
Why?
| | Proto-Oncogene Proteins | 1 | 2017 | 624 | 0.410 |
Why?
| | Vital Capacity | 4 | 2026 | 292 | 0.360 |
Why?
| | Inflammation | 2 | 2025 | 2878 | 0.340 |
Why?
| | Lung | 4 | 2019 | 4106 | 0.310 |
Why?
| | Respiratory Function Tests | 3 | 2026 | 544 | 0.290 |
Why?
| | Pulmonary Fibrosis | 2 | 2025 | 395 | 0.270 |
Why?
| | Myositis | 1 | 2025 | 57 | 0.220 |
Why?
| | Bronchial Provocation Tests | 1 | 2024 | 47 | 0.210 |
Why?
| | Forced Expiratory Volume | 1 | 2025 | 450 | 0.200 |
Why?
| | Asthma | 1 | 2015 | 1797 | 0.190 |
Why?
| | Diagnosis, Differential | 2 | 2019 | 1508 | 0.190 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 2025 | 638 | 0.180 |
Why?
| | Extracellular Traps | 1 | 2021 | 52 | 0.170 |
Why?
| | Exercise | 2 | 2024 | 2198 | 0.170 |
Why?
| | Anti-Citrullinated Protein Antibodies | 1 | 2021 | 127 | 0.160 |
Why?
| | Lactic Acid | 1 | 2022 | 295 | 0.160 |
Why?
| | Prognosis | 2 | 2026 | 4316 | 0.150 |
Why?
| | Sputum | 1 | 2021 | 302 | 0.150 |
Why?
| | Macrophages | 2 | 2018 | 1507 | 0.150 |
Why?
| | Humans | 17 | 2026 | 145475 | 0.150 |
Why?
| | Bleomycin | 2 | 2018 | 255 | 0.140 |
Why?
| | Radiologists | 1 | 2019 | 61 | 0.140 |
Why?
| | Fibrosis | 1 | 2021 | 559 | 0.140 |
Why?
| | Fatty Acids | 1 | 2022 | 457 | 0.140 |
Why?
| | Positron Emission Tomography Computed Tomography | 1 | 2019 | 117 | 0.140 |
Why?
| | CASP8 and FADD-Like Apoptosis Regulating Protein | 1 | 2018 | 20 | 0.130 |
Why?
| | CD11 Antigens | 1 | 2018 | 30 | 0.130 |
Why?
| | Cause of Death | 1 | 2019 | 470 | 0.120 |
Why?
| | Mortality | 1 | 2019 | 378 | 0.120 |
Why?
| | Gene Deletion | 1 | 2018 | 391 | 0.120 |
Why?
| | CD11b Antigen | 1 | 2016 | 60 | 0.120 |
Why?
| | Antigens, Differentiation, Myelomonocytic | 1 | 2016 | 66 | 0.120 |
Why?
| | Phagocytes | 1 | 2016 | 80 | 0.110 |
Why?
| | Auscultation | 1 | 2015 | 4 | 0.110 |
Why?
| | Middle Aged | 8 | 2026 | 36215 | 0.110 |
Why?
| | Radiography, Thoracic | 1 | 2015 | 172 | 0.100 |
Why?
| | Mice, Inbred C57BL | 4 | 2017 | 5983 | 0.100 |
Why?
| | Male | 11 | 2026 | 72843 | 0.100 |
Why?
| | Severity of Illness Index | 2 | 2026 | 2930 | 0.100 |
Why?
| | Neovascularization, Physiologic | 1 | 2014 | 192 | 0.090 |
Why?
| | Antigens, CD | 1 | 2016 | 558 | 0.090 |
Why?
| | Arthritis, Rheumatoid | 1 | 2021 | 1180 | 0.090 |
Why?
| | Regeneration | 1 | 2014 | 197 | 0.090 |
Why?
| | Female | 12 | 2026 | 78845 | 0.080 |
Why?
| | Mice, Knockout | 1 | 2017 | 3124 | 0.080 |
Why?
| | Apoptosis | 1 | 2017 | 2440 | 0.070 |
Why?
| | Animals | 8 | 2025 | 38030 | 0.070 |
Why?
| | Retrospective Studies | 4 | 2026 | 17291 | 0.060 |
Why?
| | Mice | 4 | 2018 | 18329 | 0.060 |
Why?
| | Adenoviridae Infections | 1 | 2005 | 20 | 0.060 |
Why?
| | Enterotoxins | 1 | 2005 | 89 | 0.060 |
Why?
| | Aged | 4 | 2026 | 26153 | 0.060 |
Why?
| | Carbon Dioxide | 1 | 2026 | 227 | 0.050 |
Why?
| | Intracellular Fluid | 1 | 2003 | 25 | 0.050 |
Why?
| | Signal Transduction | 1 | 2017 | 5216 | 0.050 |
Why?
| | Bronchoscopy | 1 | 2025 | 227 | 0.050 |
Why?
| | ROC Curve | 1 | 2025 | 617 | 0.050 |
Why?
| | Interleukin-4 | 1 | 2003 | 207 | 0.050 |
Why?
| | Th2 Cells | 1 | 2003 | 175 | 0.050 |
Why?
| | Adjuvants, Immunologic | 1 | 2003 | 243 | 0.040 |
Why?
| | Sulfhydryl Compounds | 1 | 2003 | 189 | 0.040 |
Why?
| | Pyridones | 1 | 2023 | 209 | 0.040 |
Why?
| | Pneumonia | 2 | 2017 | 636 | 0.040 |
Why?
| | Predictive Value of Tests | 1 | 2026 | 2121 | 0.040 |
Why?
| | Genomics | 1 | 2025 | 825 | 0.040 |
Why?
| | Occupations | 1 | 2019 | 50 | 0.040 |
Why?
| | Nuclear Proteins | 1 | 2003 | 740 | 0.030 |
Why?
| | Lipid Metabolism | 1 | 2022 | 529 | 0.030 |
Why?
| | Double-Blind Method | 1 | 2023 | 2062 | 0.030 |
Why?
| | Oxidation-Reduction | 1 | 2022 | 1067 | 0.030 |
Why?
| | Forecasting | 1 | 2019 | 390 | 0.030 |
Why?
| | Mice, Transgenic | 2 | 2016 | 2188 | 0.030 |
Why?
| | Chronic Disease | 1 | 2022 | 1808 | 0.030 |
Why?
| | Organ Specificity | 1 | 2016 | 309 | 0.030 |
Why?
| | Cell Lineage | 1 | 2017 | 377 | 0.030 |
Why?
| | Disease Progression | 1 | 2023 | 2864 | 0.030 |
Why?
| | Sequence Analysis, RNA | 1 | 2017 | 442 | 0.030 |
Why?
| | Cohort Studies | 1 | 2025 | 6013 | 0.030 |
Why?
| | Disease Models, Animal | 1 | 2025 | 4560 | 0.030 |
Why?
| | Inflammation Mediators | 1 | 2017 | 506 | 0.030 |
Why?
| | Pandemics | 1 | 2023 | 1707 | 0.030 |
Why?
| | Cytokines | 2 | 2017 | 2067 | 0.030 |
Why?
| | Transcriptional Activation | 1 | 2016 | 372 | 0.030 |
Why?
| | Endothelium | 1 | 2014 | 119 | 0.030 |
Why?
| | Lipopolysaccharides | 1 | 2016 | 858 | 0.020 |
Why?
| | Metabolomics | 1 | 2017 | 732 | 0.020 |
Why?
| | Mice, Inbred BALB C | 2 | 2005 | 1261 | 0.020 |
Why?
| | United States | 2 | 2019 | 16098 | 0.020 |
Why?
| | Gene Expression | 1 | 2016 | 1476 | 0.020 |
Why?
| | Interferon-gamma | 2 | 2005 | 784 | 0.020 |
Why?
| | Flow Cytometry | 1 | 2014 | 1162 | 0.020 |
Why?
| | Gene Expression Profiling | 1 | 2017 | 1767 | 0.020 |
Why?
| | Cell Proliferation | 1 | 2017 | 2507 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2017 | 3413 | 0.020 |
Why?
| | Adult | 2 | 2023 | 40777 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2023 | 11772 | 0.020 |
Why?
| | Risk Factors | 1 | 2021 | 10885 | 0.020 |
Why?
| | Splenomegaly | 1 | 2005 | 15 | 0.010 |
Why?
| | Mice, Inbred DBA | 1 | 2005 | 182 | 0.010 |
Why?
| | Poly(ADP-ribose) Polymerases | 1 | 2005 | 88 | 0.010 |
Why?
| | Alanine Transaminase | 1 | 2005 | 151 | 0.010 |
Why?
| | Interphase | 1 | 2003 | 38 | 0.010 |
Why?
| | STAT6 Transcription Factor | 1 | 2003 | 24 | 0.010 |
Why?
| | Transcription Factor AP-1 | 1 | 2003 | 79 | 0.010 |
Why?
| | Receptors, Antigen, T-Cell, alpha-beta | 1 | 2005 | 334 | 0.010 |
Why?
| | Active Transport, Cell Nucleus | 1 | 2003 | 117 | 0.010 |
Why?
| | CD3 Complex | 1 | 2003 | 112 | 0.010 |
Why?
| | NFATC Transcription Factors | 1 | 2003 | 94 | 0.010 |
Why?
| | Antigen-Presenting Cells | 1 | 2003 | 159 | 0.010 |
Why?
| | Interleukin-12 | 1 | 2003 | 115 | 0.010 |
Why?
| | Solubility | 1 | 2003 | 240 | 0.010 |
Why?
| | Th1 Cells | 1 | 2003 | 139 | 0.010 |
Why?
| | Acetylcysteine | 1 | 2003 | 139 | 0.010 |
Why?
| | Drug Combinations | 1 | 2003 | 396 | 0.010 |
Why?
| | Spleen | 1 | 2003 | 508 | 0.010 |
Why?
| | Down-Regulation | 1 | 2003 | 618 | 0.010 |
Why?
| | Trans-Activators | 1 | 2003 | 396 | 0.010 |
Why?
| | Up-Regulation | 1 | 2003 | 847 | 0.010 |
Why?
| | Cell Nucleus | 1 | 2003 | 588 | 0.010 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2005 | 1217 | 0.010 |
Why?
| | Lymphocyte Activation | 1 | 2003 | 1132 | 0.010 |
Why?
| | Liver | 1 | 2005 | 1896 | 0.010 |
Why?
| | DNA-Binding Proteins | 1 | 2003 | 1480 | 0.010 |
Why?
| | Cells, Cultured | 1 | 2003 | 4148 | 0.010 |
Why?
| | Transcription Factors | 1 | 2003 | 1734 | 0.010 |
Why?
|
|
Mohning's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|